Predictors of Prognosis in IBD Patients
Predictors of Response After Induction Therapy With TNF-alpha Inhibitor in Inflammatory Bowel Disease, Comparison to Normal
Seoul National University Bundang Hospital
100 participants
Mar 11, 2013
OBSERVATIONAL
Conditions
Summary
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Eligibility
Inclusion Criteria3
- control group: Patients who do not have colitis, cancer, and advanced polyp (the number of polyps ≥ 3, the size of polyps ≥ 1cm, high-grade adenoma, villous adenoma)
- TNF-α inhibitor-naive IBD group: IBD patients who do not have a history of TNF-α inhibitor treatment
- TNF-α inhibitor-treated IBD group: IBD patients who are treated with TNF-α inhibitor
Exclusion Criteria2
- Age under 18 years
- Patients who were treated with antibiotics or probiotics within the last 3 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
When patients have colonoscopy or sigmoidoscopy for evaluation of their disease course, biopsied samples are collected. In the IBD group, samples are obtained at endoscopically active and/or inactive lesions. In the control group, samples are obtained at endoscopically normal lesions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05653011